Literature DB >> 16959345

Esophageal cancer: determination of internal target volume for conformal radiotherapy.

F Lorchel1, J L Dumas, A Noël, D Wolf, J F Bosset, P Aletti.   

Abstract

BACKGROUND AND
PURPOSE: To evaluate esophageal tumor and OAR movement during the respiratory cycle in order to obtain optimal values for ITV and PRV. To correlate tumor motion with chest wall displacement - information of value in the free-breathing gating system. MATERIAL AND
METHOD: Inclusion criteria were: histologically proven squamous-cell carcinoma (SCC) or adenocarcinoma at stage T3 - T4 NX or TX N1 M0 according to the UICC 1997 classification. Two spiral scans were performed with breath-hold respiration under spirometric control: one at end expiration (EBH) and the other at end inspiration (IBH). Displacements between exhalation and inhalation were calculated according to ICRU report 42 recommendations. For the correlation study, CT-scan acquisition was performed at the isocenter over a 20 - 40 s period. After Fourier Transform, frequency spectra for amplitude and phase of tumor and chest wall motions were performed for each patient.
RESULTS: Cumulative distribution of CTV motion in absolute values showed that 95% of data ranged from 0 to 1 cm. Cumulative distribution of GTV motion in absolute values showed that 95% of data ranged from 0 to 0.8 cm. The correlation study demonstrated no specific relationship between respiratory and esophageal motions.
CONCLUSION: The ITV margin for 3D conformal radiotherapy in esophageal cancer was 1 cm when 95% of motions were taken into account in this clinical study involving eight patients. Before using a free-breathing gating system, the correlation between external markers and target displacement during irradiation must be established for each patient.

Entities:  

Mesh:

Year:  2006        PMID: 16959345     DOI: 10.1016/j.radonc.2006.08.003

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  6 in total

Review 1.  Technological advances in radiotherapy for esophageal cancer.

Authors:  Milan Vosmik; Jiri Petera; Igor Sirak; Miroslav Hodek; Petr Paluska; Jiri Dolezal; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2010-11-28       Impact factor: 5.742

2.  Quantifying the interfractional displacement of the gastroesophageal junction during radiation therapy for esophageal cancer.

Authors:  Jingya Wang; Steven H Lin; Lei Dong; Peter Balter; Radhe Mohan; Ritsuko Komaki; James D Cox; George Starkschall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-21       Impact factor: 7.038

3.  Esophageal motion during radiotherapy: quantification and margin implications.

Authors:  R J Cohen; K Paskalev; S Litwin; R A Price; S J Feigenberg; A A Konski
Journal:  Dis Esophagus       Date:  2010-01-15       Impact factor: 3.429

4.  Differences in displacement of the proximal and distal ends of mid-upper thoracic esophageal squamous cell carcinoma.

Authors:  Guoqin Qiu; Dengshun Wen; Xianghui DU; Liming Sheng; Xia Zhou; Yongling Ji; Wuan Bao; Danhong Zhang; Lei Cheng
Journal:  Mol Clin Oncol       Date:  2016-05-11

5.  Reduced lung dose during radiotherapy for thoracic esophageal carcinoma: VMAT combined with active breathing control for moderate DIBH.

Authors:  Guanzhong Gong; Ruozheng Wang; Yujie Guo; Deyin Zhai; Tonghai Liu; Jie Lu; Jinhu Chen; Chengxin Liu; Yong Yin
Journal:  Radiat Oncol       Date:  2013-12-20       Impact factor: 3.481

6.  Detection of interfraction displacement and volume variance during radiotherapy of primary thoracic esophageal cancer based on repeated four-dimensional CT scans.

Authors:  Jin Zhi Wang; Jian Bin Li; Wei Wang; Huan Peng Qi; Zhi Fang Ma; Ying Jie Zhang; Ting Yong Fan; Qian Shao; Min Xu
Journal:  Radiat Oncol       Date:  2013-09-27       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.